Apologies for another thread on PE exits. Would love to know how HL RX exits into high-AUM PE compares to the placements of mid-BB groups (Barclays Industrials, BofA FSG, Citi M&A) and firms such as Gugg or GHL M&A.
Thanks!
| +190 | Evercore > Goldman and I don’t think it’s particularly close anymore | 65 | 19h |
| +157 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +86 | UBS Offer Day | 32 | 3h |
| +84 | Think Twice before Recruiting for HOUSTON IB!! | 44 | 6h |
| +71 | I hate Wells Fargo | 19 | 1d |
| +52 | No return offer - feeling like a failure is an understatement | 21 | 10h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 1d |
| +47 | WF Return offers | 28 | 3d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
| +39 | Should I go back into a junior IBD role for comp? | 16 | 3d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Also curious.
bump
HL Rx exits can be good if you take a look. However it's not a straight shoot to Mf. The group sizes are huge as Houlihan, they have like 5 offices with 10-20 analysts each. This means that your deal flow might not be super good depending on staffing. Would probably argue BofA FSG has better exits than HL Rx but both strong.
This is simply wrong (at least for the NYC office). Intern classes are anywhere from 8-11 people (last 3y), of which only around 50% return- the other half goes straight to buy-side analyst programs (last year, they had 2 people going to WP, and one to BX for FT) or firms like Qatalyst.
Deal flow does not matter for on-cycle recruiting post-covid, since headhunters start reaching out to first-years before they reach the desk. The main proxy for MF interviews are group selectivity, resume (GPA), and school, and I would argue that HLRX is significantly more selective than any of the mid-BBs (at least for NYC).
For example, last year they had two people going to APO HV - especially on a per-capita basis, exits are better. Hope this helps.
Disclaimer: I did not intern/ work there, but I am an incoming FT at a comparable RX group.
How Hard is it to get a FT role for RX at HL or PJT RSSG? I'm a SA for a Tier2 RX firm and want to trade up(not buyside supportive my firm).
For comparison, other firms have like 1/3 the class that size.Also just for your reference, 2 people last year went to Apollo Buyout from Evercore Rx and their class is wayyyyy smaller. HL and EVR are still good.
On a per-capita basis:
HL NYC/LA > BAML/Citi > HL CHI/MN/Dallas
No one is taking Citi/BofA over HL RX
Quia eligendi voluptatem cumque rem. Ea nihil id sed qui soluta ut ipsa. Sunt fugit mollitia ad voluptate voluptates. Fuga voluptate quasi beatae officiis. Magnam nam omnis placeat consectetur.
Velit repellendus et ut facilis consequatur velit. Ad commodi minus sed alias necessitatibus. Rerum consectetur quibusdam quibusdam laudantium. Aut aut eum eum alias tempore. Rem aut laborum consequatur tempore. Voluptatum non quas est adipisci voluptas amet quis.
Natus mollitia excepturi esse ipsam ipsa eum molestiae odio. Vel incidunt rem vero sapiente maiores vel ea. Officia in non rem vitae. Delectus natus dignissimos nulla est. Voluptate ex aut vero numquam sed.
Et voluptatibus iste porro sequi. Ipsa est iure ducimus repellendus sit vel quia. Accusantium dolorum voluptatem sequi sit autem. Quasi consequatur enim consequatur cumque voluptas quos architecto totam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...